Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 6
1978 2
1979 1
1980 3
1981 3
1982 2
1983 5
1984 1
1985 6
1986 5
1988 2
1989 6
1990 3
1991 6
1992 4
1994 3
1995 10
1996 4
1997 5
1998 4
1999 1
2000 2
2002 2
2003 1
2004 2
2005 1
2006 2
2009 1
2010 1
2011 1
2012 4
2015 1
2016 1
2017 2
2018 1
2019 1
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.
Claus C, Ferrara C, Xu W, Sam J, Lang S, Uhlenbrock F, Albrecht R, Herter S, Schlenker R, Hüsser T, Diggelmann S, Challier J, Mössner E, Hosse RJ, Hofer T, Brünker P, Joseph C, Benz J, Ringler P, Stahlberg H, Lauer M, Perro M, Chen S, Küttel C, Bhavani Mohan PL, Nicolini V, Birk MC, Ongaro A, Prince C, Gianotti R, Dugan G, Whitlow CT, Solingapuram Sai KK, Caudell DL, Burgos-Rodriguez AG, Cline JM, Hettich M, Ceppi M, Giusti AM, Crameri F, Driessen W, Morcos PN, Freimoser-Grundschober A, Levitsky V, Amann M, Grau-Richards S, von Hirschheydt T, Tournaviti S, Mølhøj M, Fauti T, Heinzelmann-Schwarz V, Teichgräber V, Colombetti S, Bacac M, Zippelius A, Klein C, Umaña P. Claus C, et al. Among authors: schlenker r. Sci Transl Med. 2019 Jun 12;11(496):eaav5989. doi: 10.1126/scitranslmed.aav5989. Sci Transl Med. 2019. PMID: 31189721 Free PMC article.
CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.
Bacac M, Colombetti S, Herter S, Sam J, Perro M, Chen S, Bianchi R, Richard M, Schoenle A, Nicolini V, Diggelmann S, Limani F, Schlenker R, Hüsser T, Richter W, Bray-French K, Hinton H, Giusti AM, Freimoser-Grundschober A, Lariviere L, Neumann C, Klein C, Umaña P. Bacac M, et al. Among authors: schlenker r. Clin Cancer Res. 2018 Oct 1;24(19):4785-4797. doi: 10.1158/1078-0432.CCR-18-0455. Epub 2018 May 1. Clin Cancer Res. 2018. PMID: 29716920 Free article.
Effects and effectiveness of telemedicine.
Grigsby J, Kaehny MM, Sandberg EJ, Schlenker RE, Shaughnessy PW. Grigsby J, et al. Among authors: schlenker re. Health Care Financ Rev. 1995 Fall;17(1):115-31. Health Care Financ Rev. 1995. PMID: 10153466 Free PMC article. Review.
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.
Herter S, Morra L, Schlenker R, Sulcova J, Fahrni L, Waldhauer I, Lehmann S, Reisländer T, Agarkova I, Kelm JM, Klein C, Umana P, Bacac M. Herter S, et al. Among authors: schlenker r. Cancer Immunol Immunother. 2017 Jan;66(1):129-140. doi: 10.1007/s00262-016-1927-1. Epub 2016 Nov 17. Cancer Immunol Immunother. 2017. PMID: 27858101 Free PMC article.
Volume/outcome relationships in small rural hospitals.
Schlenker RE, Hittle DF, Hrincevich CA, Kaehny MM. Schlenker RE, et al. J Rural Health. 1996 Fall;12(5):395-409. doi: 10.1111/j.1748-0361.1996.tb00807.x. J Rural Health. 1996. PMID: 10166136 Review.
Measuring and assuring the quality of home health care.
Shaughnessy PW, Crisler KS, Schlenker RE, Arnold AG, Kramer AM, Powell MC, Hittle DF. Shaughnessy PW, et al. Among authors: schlenker re. Health Care Financ Rev. 1994 Fall;16(1):35-67. Health Care Financ Rev. 1994. PMID: 10140157 Free PMC article. Review.
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page